CSI Market
Sign In | Register

Windtree Therapeutics Inc (WINT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access WINT Annual Cash Flow →
Quarterly cash flow trends provide additional context on Windtree Therapeutics Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
9 Months 		(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Operating Activities
Income-42.76
Depreciation & amortization0.39
Amortization of Other Assets0.18
Increase (Decrease) in Deferred Revenue0.00
Impairment of Intangible Assets, Finite-lived16.13
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation0.12
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.03
Provision For Excess Inventory-
Gains Losses On Restructuring Of Debt-
Increase Decrease In Deferred Revenue Current-
Contract With Customer Liability Revenue Recognized-
Operating Lease Right Of Use Asset Amortization-
Non Cash Lease Expense-
Operating Lease Right Of Use Asset Amortization Expense-
Non Cash Expense Related To Equity Consideration For A Service Agreement-
Impairment Of Intangible Assets Excluding Goodwill-
Inprocess Research And Development Costs-
Gain Loss On Convertible Promissory Note And Derivative Liability14.97
Gain Loss On Deposit Settlement0.65
Gain Loss On Issuance Of Convertible Notes And Warrants7.44
Change In Fair Value Of Senior Secured Notes-
Increase Decrease Operating Lease Liability-0.38
Increase Decrease Operating Lease Liability-0.38
Income taxes-3.23
Unrealized Gain (Loss) on Derivatives-0.80
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-0.23
Increase (Decrease) in Accrued Liabilities0.12
Payments for (Proceeds from) Other Deposits-1.40
Increase (Decrease) in Prepaid Expense and Other Assets0.53
Other Working Capital-0.17
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.65
Discontinued operations0.00
Net Cash flow from Operating Activities-11.44
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Fair Value Of Warrant Modifications Related To Warrant Exercise Inducement-
Debt Conversion Converted Instrument Amount-
Notes Issued-
Fair Value Of Warrants Issued-
Fair Value Upon Issuance Of Derivative Liability Related To Convertible Notes-
Conversion Of Stock Amount Issued-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable-4.57
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-1.40
Discontinued operations0.00
Net Cash Flow from Investing Activities-5.97
Financing Activities
Short-term debt Net0.09
Other borrowing transactions0.00
Long-term debt - borrowings4.30
Long-term debt - repayments-2.80
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.35
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net13.97
Proceeds From Warrants And Stock Options Exercised-
Proceeds From Research And Development Funding Arrangement-
Proceeds From Issuance Of Common Stock And Warrants-
Payments For Early Extinguishment Of Debt-
Repayments Of Loans Payable Shortterm Debt-
Proceeds From Senior Convertible Debt-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-0.09
Net Cash Flow from Financing Activities15.83
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-11.44
Total Cash Flow-1.57
4 historic quarters locked

Sign in to unlock the full Windtree Therapeutics Inc cash flow history.

Sign In Create Free Account

About Windtree Therapeutics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-25-035751

Figures are derived from filed reports and may be restated. Historical data is subject to revision.